Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management.

Keeton CP, Kolos AC, Walkup JT.

Paediatr Drugs. 2009;11(3):171-83. doi: 10.2165/00148581-200911030-00003. Review.

PMID:
19445546
2.

Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.

Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH.

JAMA Pediatr. 2017 Nov 1;171(11):1049-1056. doi: 10.1001/jamapediatrics.2017.3036. Review.

PMID:
28859190
3.

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ.

Cochrane Database Syst Rev. 2015 Jan 20;1:CD007505. doi: 10.1002/14651858.CD007505.pub2. Review.

PMID:
25601826
4.

WCA recommendations for the long-term treatment of generalized anxiety disorder.

Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61. Review.

PMID:
14767398
5.

Pregabalin versus sertraline in generalized anxiety disorder. An open label study.

Cvjetkovic-Bosnjak M, Soldatovic-Stajic B, Babovic SS, Boskovic K, Jovicevic M.

Eur Rev Med Pharmacol Sci. 2015;19(11):2120-4.

6.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
7.

Treatment of Anxiety Disorders: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2005 Nov.

8.

Child/Adolescent anxiety multimodal study: evaluating safety.

Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B.

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):180-90. doi: 10.1016/j.jaac.2014.12.015. Epub 2014 Dec 31.

9.

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC.

N Engl J Med. 2008 Dec 25;359(26):2753-66. doi: 10.1056/NEJMoa0804633. Epub 2008 Oct 30. Erratum in: N Engl J Med. 2013 Jan 31;368(5):490.

10.

Nature, assessment, and treatment of generalized anxiety disorder in children.

Hudson JL, Deveney C, Taylor L.

Pediatr Ann. 2005 Feb;34(2):97-106. Review.

PMID:
15768686
11.

Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.

Schneier FR, Belzer KD, Kishon R, Amsel L, Simpson HB.

J Nerv Ment Dis. 2010 Jun;198(6):458-61. doi: 10.1097/NMD.0b013e3181da4d77.

PMID:
20531128
12.

Pediatric anxiety disorders: management in primary care.

Sakolsky D, Birmaher B.

Curr Opin Pediatr. 2008 Oct;20(5):538-43. doi: 10.1097/MOP.0b013e32830fe3fa. Review.

PMID:
18781116
13.

Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.

Caporino NE, Brodman DM, Kendall PC, Albano AM, Sherrill J, Piacentini J, Sakolsky D, Birmaher B, Compton SN, Ginsburg G, Rynn M, McCracken J, Gosch E, Keeton C, March J, Walkup JT.

J Am Acad Child Adolesc Psychiatry. 2013 Jan;52(1):57-67. doi: 10.1016/j.jaac.2012.10.006. Epub 2012 Nov 30.

14.

[Treatment of generalized anxiety: new pharmacologic approaches].

Boulenger JP.

Encephale. 1995 Nov-Dec;21(6):459-66. Review. French.

PMID:
8674471
15.
16.

Benefits of child-focused anxiety treatments for parents and family functioning.

Keeton CP, Ginsburg GS, Drake KL, Sakolsky D, Kendall PC, Birmaher B, Albano AM, March JS, Rynn M, Piacentini J, Walkup JT.

Depress Anxiety. 2013 Sep;30(9):865-72. doi: 10.1002/da.22055. Epub 2013 Feb 6.

17.

[Sensitivity and specificity of the worry and anxiety questionnaire (WAQ) in a sample of health-care users in the province of Quebec].

Belleville G, Bélanger L, Ladouceur R, Morin CM.

Encephale. 2008 Jun;34(3):240-8. doi: 10.1016/j.encep.2007.01.008. Epub 2007 Oct 24. French.

PMID:
18558144
18.

A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):283-93. doi: 10.1016/j.jaac.2015.01.008. Epub 2015 Jan 29.

PMID:
25791145
19.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

20.

Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

CNS Drugs. 2002;16(2):139-44. Review.

PMID:
11825104

Supplemental Content

Support Center